Gleice K. Jesus

1 Introduction Kidney transplantation is recognised by the World Health Organisation (WHO) as the most effective therapeutic option for patients with end-stage renal disease, significantly improving quality of life and increasing survival rates to 83% compared with dialysis [1]. Despite these benefits, the immunosuppression required to prevent graft rejection markedly increases susceptibility to opportunistic infections, affecting up to 57.1% of recipients within 6 months post-transplant.